Kashyap Tele-Medicines Ltd - 531960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 202406-07-2024
06-07-2024
Kashyap Tele-Medicines Ltd - 531960 - Closure of Trading Window
Closure of Trading Window for quarter ended 30th June, 202429-06-2024
Kashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication-Financial Results18-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Independent Director17-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Change in Management
Re-appointment of Independent Director, Internal Auditor and Secretarial Auditor17-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Results-Financial Results For Quarter And Year Ended 31St March, 2024
Submission of financial results for quarter and year ended 31st, March, 202417-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board meeting held on 17th May, 202417-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Intimation For Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve the audited financial results for the quarter and financial year ended on 31st March 2024 and Audit Report thereon and to consider and approve the audited financial statement for the year ended on 31st March 2024 and Audit Report thereon;10-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Non-Applicability of Annual Secretarial Compliance Report for year ended 31st March, 202410-05-2024
Kashyap Tele-Medicines Ltd - 531960 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKashyap Tele-Medicines Ltd 2CIN NO.L29110MH1995PLC085738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: JYOTI SAHU Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Raghav Agrawal Designation: Director and Chief Financial Officer EmailId: [email protected] Date: 20/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.20-04-2024